A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation
- PMID: 7668822
- DOI: 10.1002/ana.410380306
A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation
Abstract
Interest is increasing concerning the role of genetic factors in the etiology of Parkinson's disease. We report the analysis of a Greek-American kindred with levodopa-responsive parkinsonism. Of the 98 individuals present in six generations of this pedigree, 16 individuals in three successive generations have developed parkinsonism. Affected members were examined both in Greece and in the United States. The clinical presentation consisted of asymmetric rigidity, resting tremor, bradykinesia, and postural instability, and symptoms were responsive to levodopa. The disease appears to be inherited in an autosomal dominant manner. The inheritance pattern and the development of parkinsonism in successive generations on two continents challenges environmental factors as the primary cause in the pathogenesis of parkinsonism in this kindred. Anticipation is present in this pedigree. The affected members in the third generation developed symptoms at ages 50 to 71, in the fourth at ages 40 to 55, and in the fifth at age 31 years. This is another example of a neurodegenerative disease with autosomal dominant inheritance and anticipation. A molecular genetic analysis of this pedigree is in progress.
Comment in
-
Kindreds of dominantly inherited Parkinson's disease: keys to the riddle.Ann Neurol. 1995 Sep;38(3):355-6. doi: 10.1002/ana.410380303. Ann Neurol. 1995. PMID: 7668819 No abstract available.
Similar articles
-
[Hereditary Parkinson disease: report of 3 families with dominant autosomal inheritance].Nervenarzt. 1993 May;64(5):331-5. Nervenarzt. 1993. PMID: 8321342 German.
-
SCA2 may present as levodopa-responsive parkinsonism.Mov Disord. 2003 Apr;18(4):425-9. doi: 10.1002/mds.10375. Mov Disord. 2003. PMID: 12671950
-
[A family of parkinsonism in which the clinical feature of constituents varied with the age of onset].Rinsho Shinkeigaku. 1994 Jul;34(7):736-8. Rinsho Shinkeigaku. 1994. PMID: 7955737 Japanese.
-
[Progress in the basic and clinical aspects of Parkinson's disease].Rinsho Shinkeigaku. 2004 Nov;44(11):741-50. Rinsho Shinkeigaku. 2004. PMID: 15651281 Review. Japanese.
-
The diagnosis of manganese-induced parkinsonism.Neurotoxicology. 2006 May;27(3):340-6. doi: 10.1016/j.neuro.2005.10.006. Epub 2005 Dec 1. Neurotoxicology. 2006. PMID: 16325915 Review.
Cited by
-
A53T in a parkinsonian family: a clinical update of the SNCA phenotypes.J Neural Transm (Vienna). 2016 Nov;123(11):1301-1307. doi: 10.1007/s00702-016-1578-6. Epub 2016 Jun 1. J Neural Transm (Vienna). 2016. PMID: 27250986 Review.
-
Parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism.BMC Neurol. 2005 Feb 22;5(1):4. doi: 10.1186/1471-2377-5-4. BMC Neurol. 2005. PMID: 15725358 Free PMC article.
-
The genetic basis of Parkinson's disease.J Neurol Neurosurg Psychiatry. 2002 Oct;73(4):363-70. doi: 10.1136/jnnp.73.4.363. J Neurol Neurosurg Psychiatry. 2002. PMID: 12235301 Free PMC article. Review.
-
SNCA-targeted epigenome therapy for Parkinson's disease alleviates pathological and behavioral perturbations in a mouse model.bioRxiv [Preprint]. 2025 Jun 17:2025.06.16.659948. doi: 10.1101/2025.06.16.659948. bioRxiv. 2025. PMID: 40667079 Free PMC article. Preprint.
-
Clinical phenotype in patients with alpha-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease.J Neurol Neurosurg Psychiatry. 2001 May;70(5):662-5. doi: 10.1136/jnnp.70.5.662. J Neurol Neurosurg Psychiatry. 2001. PMID: 11309462 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical